Dr. Dale Bredesen and Dr. Garland Glenn from The Carroll Institute were interviewed by Sarasota Magazine’s Elizabeth Dijnas for the article “A New Alzheimer’s Treatment Method Is Touted as Improving Cognition: Dr. Dale Bredesen’s ReCODE protocol stresses changes to one’s lifestyle and environment as a way to fight Alzheimer’s.”

Dr. Bredesen discussed the FDA’s controversial approval of lecanemab, his proof-of-concept trial where 84 percent of participants improved their cognition (unlike lecanemab and all currently available AD drugs which do nothing but slow the progression of the disease), his ReCODE Protocol the basis of the ReCODE Program™ and much more.

Read the full article here.

Share This: